Skip to main content

Nuvaira, Plymouth-based med-tech firm, closes on $79 million round to fund trials of lung-disease treatment

Nuvaira Inc. has closed on $79 million in equity financing led by Silicon Valley firm U.S. Venture Partners, the Plymouth medical-technology company announced Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.